This underscores the importance of specific diagnostic testing in identifying cryptic fusions or rare subsets of CBFB::MYH11 AML that may otherwise be overlooked by morphological, conventional cytogenetic and molecular testing. The gene discussed is CBFB; the disease is acute myeloid leukemia.